HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
116626.0,290736,2144-10-18 06:13:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Started Daptomycin per ID recs
   Checking cyptococcus, [** 2501**], CMV
   TTE ordered
   Got IVF in attempts to wean pressors, able to wean Levo to 0.04
   Got Clonazepam 1mg X 1 at night for anxiety
 MULTI LUMEN - START [**2144-10-17**] 08:15 AM
 FEVER - 102.0
F - [**2144-10-17**] 10:46 PM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Daptomycin - [**2144-10-17**] 08:39 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-17**] 10:25 PM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-18**] 06:10 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.9
C (102
   Tcurrent: 37.1
C (98.8
   HR: 62 (53 - 98) bpm
   BP: 94/48(59) {84/42(56) - 115/80(85)} mmHg
   RR: 21 (13 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 2 (2 - 12)mmHg
   Total In:
                                                                 11,160 mL
                                                                    272 mL
   PO:
                                                                  1,490 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  5,170 mL
                                                                    152 mL
   Blood products:
   Total out:
                                                                  6,445 mL
                                                                    890 mL
   Urine:
                                                                  5,445 mL
                                                                    890 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,715 mL
                                                                   -618 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: 7.42/34/32/22/-2
   Physical Examination
   VS: T97.3 HR 69 BP 84/53 RR 24  100% RA
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   65 K/uL
   10.0 g/dL
   130 mg/dL
   0.8 mg/dL
   22 mEq/L
   4.0 mEq/L
   7 mg/dL
   113 mEq/L
   141 mEq/L
   29.5 %
   5.0 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
   WBC
   4.2
   4.1
   5.0
   Hct
   29.6
   28.0
   29.5
   Plt
   58
   60
   65
   Cr
   0.7
   0.7
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:8.3 mg/dL, Mg++:2.4 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.  Given ECG conduction
   problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin and Zosyn, add Clinda per ID recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10
   - [**Last Name (un) **] stim test today
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeding. DIC labs negative.
   -monitor PLT, coags
   ..
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
   ------ Protected Section ------
   MICU ATTNEDING PROGRESS NOTE
   I saw and examined the patient and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   note above, including the assessment and plan. I would emphasize and
   add the following points: 48 yo M with HIV/AIDS, HCV, presented
   yesterday with temps to 103-104X 1 day, HA and body aches. Admits to
   crystal meth injection [**10-15**] prior to start of sx
s.  In ED febrile and
   became hypotensive with fluid resusc and levophed started after IJ
   placement.  Pan cx
d, had LP which was unremarkable for bacterial men.
   Received empiric antbx and ID consulted.  Admitted to MICU for further
   care.  Fluid resuscitated and now weaning down levophed.  EP consulted
   yesterday for bradycardia and ? heart block vs sick sinus.
   Exam notable for Tm 102 Tc98.8 BP 94/48  HR 62  RR 21  sat 99% on RA. +
   4.7 L/24 hrs  Alert, appropriate and pleasant in NAD, MMM, R IJ site
   c/d/i, lungs CTA, RR, benign abd, no erythema or abscess at skin
   injection site, no edema, warm ext
   Labs notable for WBC 5.0  HCT 29.6, plt 65   K 4.0 , co2 22  cr 0.8,
   lactate 1.7, tox screen neg MICRO: csf, bl urine cxs pending.
   No new imaging.
   Agree with plan to continue aggressive infectious workup for source of
   sepsis with fevers, hypotension.  DDX includes injection related
   bacteremia, SBE, viral process, influenza, pna (no evidence on CXR) as
   well as atypical infections (such as CMV, crypto, [**Month/Day (4) 2501**]).  ID c/s
   appreciated.  No murmur on exam or stigmata of SBE, but will
   pursue echo. Will continue Zosyn and dapto (switched from vanco per
   ID). Although improving overall, unable to wean off pressor despite
   aggressive IVF.  Will continue to bolus for CVP 8-12.  Will add clinda
   (per ID) and will check [**Last Name (un) **] stim to eval for adrenal
   insuff/adrenalitis.  F/u cx data, check influenza swab, repeat set
   blood cxs and send off serologies for cmv, crypto and [**Last Name (un) 2501**].
   Thrombocytopenia and coagulapathy stable without evidence of DIC.
   Regarding his cardiac conduction process this seems most likely a rate
   related process with junctional escape--ep input appreciated.  Remains
   now in a NSR.  Continue tele.
   Remainder of plan as outlined above.
   Patient is critically ill
   Total time: 40 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 143**] [**Last Name (NamePattern1) 144**], MD
   on:[**2144-10-18**] 02:54 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Started Daptomycin per ID recs
   Checking cyptococcus, [** 2501**], CMV
   TTE ordered
   Got IVF in attempts to wean pressors, able to wean Levo to 0.04
   Got Clonazepam 1mg X 1 at night for anxiety
 MULTI LUMEN - START [**2144-10-17**] 08:15 AM
 FEVER - 102.0
F - [**2144-10-17**] 10:46 PM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Daptomycin - [**2144-10-17**] 08:39 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-17**] 10:25 PM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-18**] 06:10 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.9
C (102
   Tcurrent: 37.1
C (98.8
   HR: 62 (53 - 98) bpm
   BP: 94/48(59) {84/42(56) - 115/80(85)} mmHg
   RR: 21 (13 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 2 (2 - 12)mmHg
   Total In:
                                                                 11,160 mL
                                                                    272 mL
   PO:
                                                                  1,490 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  5,170 mL
                                                                    152 mL
   Blood products:
   Total out:
                                                                  6,445 mL
                                                                    890 mL
   Urine:
                                                                  5,445 mL
                                                                    890 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,715 mL
                                                                   -618 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: 7.42/34/32/22/-2
   Physical Examination
   VS: T97.3 HR 69 BP 84/53 RR 24  100% RA
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   65 K/uL
   10.0 g/dL
   130 mg/dL
   0.8 mg/dL
   22 mEq/L
   4.0 mEq/L
   7 mg/dL
   113 mEq/L
   141 mEq/L
   29.5 %
   5.0 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
   WBC
   4.2
   4.1
   5.0
   Hct
   29.6
   28.0
   29.5
   Plt
   58
   60
   65
   Cr
   0.7
   0.7
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:8.3 mg/dL, Mg++:2.4 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.  Given ECG conduction
   problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin and Zosyn, add Clinda per ID recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10
   - [**Last Name (un) **] stim test today
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeding. DIC labs negative.
   -monitor PLT, coags
   ..
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
   ------ Protected Section ------
   MICU ATTNEDING PROGRESS NOTE
   I saw and examined the patient and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   note above, including the assessment and plan. I would emphasize and
   add the following points: 48 yo M with HIV/AIDS, HCV, presented
   yesterday with temps to 103-104X 1 day, HA and body aches. Admits to
   crystal meth injection [**10-15**] prior to start of sx
s.  In ED febrile and
   became hypotensive with fluid resusc and levophed started after IJ
   placement.  Pan cx
d, had LP which was unremarkable for bacterial men.
   Received empiric antbx and ID consulted.  Admitted to MICU for further
   care.  Fluid resuscitated and now weaning down levophed.  EP consulted
   yesterday for bradycardia and ? heart block vs sick sinus.
   Exam notable for Tm 102 Tc98.8 BP 94/48  HR 62  RR 21  sat 99% on RA. +
   4.7 L/24 hrs  Alert, appropriate and pleasant in NAD, MMM, R IJ site
   c/d/i, lungs CTA, RR, benign abd, no erythema or abscess at skin
   injection site, no edema, warm ext
   Labs notable for WBC 5.0  HCT 29.6, plt 65   K 4.0 , co2 22  cr 0.8,
   lactate 1.7, tox screen neg MICRO: csf, bl urine cxs pending.
   No new imaging.
   Agree with plan to continue aggressive infectious workup for source of
   sepsis with fevers, hypotension.  DDX includes injection related
   bacteremia, SBE, viral process, influenza, pna (no evidence on CXR) as
   well as atypical infections (such as CMV, crypto, [**Month/Day (4) 2501**]).  ID c/s
   appreciated.  No murmur on exam or stigmata of SBE, but will
   pursue echo. Will continue Zosyn and dapto (switched from vanco per
   ID). Although improving overall, unable to wean off pressor despite
   aggressive IVF.  Will continue to bolus for CVP 8-12.  Will add clinda
   (per ID) and will check [**Last Name (un) **] stim to eval for adrenal
   insuff/adrenalitis.  F/u cx data, check influenza swab, repeat set
   blood cxs and send off serologies for cmv, crypto and [**Last Name (un) 2501**].
   Thrombocytopenia and coagulapathy stable without evidence of DIC.
   Regarding his cardiac conduction process this seems most likely a rate
   related process with junctional escape--ep input appreciated.  Remains
   now in a NSR.  Continue tele.
   Remainder of plan as outlined above.
   Patient is critically ill
   Total time: 40 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 143**] [**Last Name (NamePattern1) 144**], MD
   on:[**2144-10-18**] 02:54 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 48-year-old male with HIV and HCV who was admitted to the ICU with fevers and hypotension, concerning for sepsis. He has a history of injection drug use and has recently injected crystal meth. His current vital signs include a temperature of 102.0°F, heart rate of 62 beats per minute, and blood pressure of 94/48 mmHg. He is receiving antibiotics, including Daptomycin and Zosyn, and is being monitored for sepsis.

Potential Medical Complications:

1. Sepsis: The patient's fever and hypotension are concerning for sepsis, which can lead to organ dysfunction and death if not promptly treated.
2. Bacteremia: The patient's history of injection drug use and recent injection of crystal meth increase his risk of developing bacteremia, which can lead to septicemia and death.
3. Viral respiratory infection: The patient's symptoms are also concerning for a viral respiratory infection, which can lead to pneumonia and respiratory failure.
4. Myocarditis: The patient's cardiac conduction problems, including junctional escape, may be related to myocarditis, which can lead to cardiac arrhythmias and death.
5. Thrombocytopenia: The patient's low platelet count may increase his risk of bleeding, particularly if he develops DIC.
6. Coagulopathy: The patient's coagulopathy may increase his risk of bleeding and may also contribute to his thrombocytopenia.
7. Liver disease: The patient's liver disease may increase his risk of developing liver failure, particularly if he develops a severe infection or experiences a prolonged period of hypotension.
8. Renal failure: The patient's history of injection drug use and recent injection of crystal meth may increase his risk of developing renal failure, particularly if he experiences a prolonged period of hypotension.
9. Pulmonary edema: The patient's history of injection drug use and recent injection of crystal meth may increase his risk of developing pulmonary edema, particularly if he experiences a prolonged period of hypotension.
10. Adrenal insufficiency: The patient's history of injection drug use and recent injection of crystal meth may increase his risk of developing adrenal insufficiency, particularly if he experiences a prolonged period of hypotension.

Recommendations:

1. Continue aggressive infectious workup for source of sepsis with fevers, hypotension.
2. Monitor patient's vital signs and laboratory results closely for signs of sepsis, including fever, tachycardia, and tachypnea.
3. Continue antibiotics, including Daptomycin and Zosyn, and monitor for signs of infection.
4. Monitor patient's cardiac conduction problems and consider performing an echocardiogram to rule out myocarditis.
5. Monitor patient's platelet count and coagulation studies and consider transfusing platelets if necessary.
6. Monitor patient's liver function tests and consider performing a liver biopsy if necessary.
7. Monitor patient's renal function and consider performing a renal biopsy if necessary.
8. Monitor patient's pulmonary function and consider performing a pulmonary function test if necessary.
9. Consider performing a thyroid function test to rule out adrenal insufficiency.
10. Consider performing a stress test to evaluate patient's cardiac function and rule out adrenal insufficiency."
116626.0,290736,2144-10-18 06:13:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Started Daptomycin per ID recs
   Checking cyptococcus, [** 2501**], CMV
   TTE ordered
   Got IVF in attempts to wean pressors, able to wean Levo to 0.04
   Got Clonazepam 1mg X 1 at night for anxiety
 MULTI LUMEN - START [**2144-10-17**] 08:15 AM
 FEVER - 102.0
F - [**2144-10-17**] 10:46 PM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Daptomycin - [**2144-10-17**] 08:39 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-17**] 10:25 PM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-18**] 06:10 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.9
C (102
   Tcurrent: 37.1
C (98.8
   HR: 62 (53 - 98) bpm
   BP: 94/48(59) {84/42(56) - 115/80(85)} mmHg
   RR: 21 (13 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 2 (2 - 12)mmHg
   Total In:
                                                                 11,160 mL
                                                                    272 mL
   PO:
                                                                  1,490 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  5,170 mL
                                                                    152 mL
   Blood products:
   Total out:
                                                                  6,445 mL
                                                                    890 mL
   Urine:
                                                                  5,445 mL
                                                                    890 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,715 mL
                                                                   -618 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: 7.42/34/32/22/-2
   Physical Examination
   VS: T97.3 HR 69 BP 84/53 RR 24  100% RA
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   65 K/uL
   10.0 g/dL
   130 mg/dL
   0.8 mg/dL
   22 mEq/L
   4.0 mEq/L
   7 mg/dL
   113 mEq/L
   141 mEq/L
   29.5 %
   5.0 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
   WBC
   4.2
   4.1
   5.0
   Hct
   29.6
   28.0
   29.5
   Plt
   58
   60
   65
   Cr
   0.7
   0.7
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:8.3 mg/dL, Mg++:2.4 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.  Given ECG conduction
   problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin and Zosyn, add Clinda per ID recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10
   - [**Last Name (un) **] stim test today
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeding. DIC labs negative.
   -monitor PLT, coags
   ..
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Started Daptomycin per ID recs
   Checking cyptococcus, [** 2501**], CMV
   TTE ordered
   Got IVF in attempts to wean pressors, able to wean Levo to 0.04
   Got Clonazepam 1mg X 1 at night for anxiety
 MULTI LUMEN - START [**2144-10-17**] 08:15 AM
 FEVER - 102.0
F - [**2144-10-17**] 10:46 PM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Daptomycin - [**2144-10-17**] 08:39 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-17**] 10:25 PM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-18**] 06:10 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.9
C (102
   Tcurrent: 37.1
C (98.8
   HR: 62 (53 - 98) bpm
   BP: 94/48(59) {84/42(56) - 115/80(85)} mmHg
   RR: 21 (13 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 2 (2 - 12)mmHg
   Total In:
                                                                 11,160 mL
                                                                    272 mL
   PO:
                                                                  1,490 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  5,170 mL
                                                                    152 mL
   Blood products:
   Total out:
                                                                  6,445 mL
                                                                    890 mL
   Urine:
                                                                  5,445 mL
                                                                    890 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,715 mL
                                                                   -618 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: 7.42/34/32/22/-2
   Physical Examination
   VS: T97.3 HR 69 BP 84/53 RR 24  100% RA
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   65 K/uL
   10.0 g/dL
   130 mg/dL
   0.8 mg/dL
   22 mEq/L
   4.0 mEq/L
   7 mg/dL
   113 mEq/L
   141 mEq/L
   29.5 %
   5.0 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
   WBC
   4.2
   4.1
   5.0
   Hct
   29.6
   28.0
   29.5
   Plt
   58
   60
   65
   Cr
   0.7
   0.7
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:8.3 mg/dL, Mg++:2.4 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.  Given ECG conduction
   problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin and Zosyn, add Clinda per ID recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10
   - [**Last Name (un) **] stim test today
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeding. DIC labs negative.
   -monitor PLT, coags
   ..
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is a 48-year-old male with HIV and HCV who is admitted to the ICU with fevers and hypotension, concern for sepsis. The patient has a history of injection drug use and has recently injected crystal meth.

The patient's vital signs are stable, with a temperature of 98.8°C, heart rate of 62 bpm, and blood pressure of 94/48 mmHg. The patient is receiving norepinephrine infusion at a rate of 0.04 mcg/kg/min to maintain blood pressure. The patient is also receiving antibiotics, including Daptomycin and Zosyn, and has been prescribed Clindamycin for 48 hours.

The patient's laboratory results show thrombocytopenia, with a platelet count of 58 K/μL, and coagulopathy, with a partial thromboplastin time of 40.4 seconds. The patient's liver function tests are abnormal, with elevated ALT and AST levels. The patient's kidney function is also abnormal, with a creatinine level of 0.8 mg/dL.

The patient's physical examination is significant for a right jugular venous catheter in place, and the patient has a slight pharyngeal exudate and erythema at the site of recent injection drug use.

The patient's assessment and plan include:

* Fever: unclear source, considering bacteremia, viral respiratory infection, or PNA, and considering LP without evidence of meningitis
* Hypotension: concerning for sepsis, continue antibiotics and levophed with goal MAP >65, attempt to wean as tolerated
* Thrombocytopenia and coagulopathy: new compared with baseline, likely acute sepsis, monitor PLT and coags
* HIV/HCV: followed by ID service, continue Kaletra and Truvada, hold off on ribaviron for now
* Anemia: per patient interferon/ribaviron therapy, gets aranesp injections, monitor HCT and PLT
* PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if needed
* FEN: regular diet, replete lytes prn
* Code Status: Full

Potential medical complications that can arise include:

* Sepsis: the patient's fever and hypotension are concerning for sepsis, and the patient's laboratory results show thrombocytopenia and coagulopathy, which are consistent with acute sepsis.
* Bacteremia: the patient's recent injection drug use and fever suggest the possibility of bacteremia.
* Viral respiratory infection: the patient's fever and respiratory symptoms suggest the possibility of viral respiratory infection.
* PNA: the patient's fever and respiratory symptoms suggest the possibility of PNA.
* Thrombocytopenia: the patient's platelet count is low, which can increase the risk of bleeding.
* Coagulopathy: the patient's partial thromboplastin time is elevated, which can increase the risk of bleeding.
* Liver dysfunction: the patient's liver function tests are abnormal, which can increase the risk of bleeding and other complications.
* Kidney dysfunction: the patient's creatinine level is elevated, which can increase the risk of kidney failure and other complications.
* HIV/HCV: the patient's HIV and HCV infections can increase the risk of opportunistic infections and other complications."
116626.0,290736,2144-10-18 06:13:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Started Daptomycin per ID recs
   Checking cyptococcus, lyme, CMV
   TTE ordered
   Got IVF in attempts to wean pressors, able to wean Levo to 0.04
   Got Clonazepam 1mg X 1 at night for anxiety
 MULTI LUMEN - START [**2144-10-17**] 08:15 AM
 FEVER - 102.0
F - [**2144-10-17**] 10:46 PM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Daptomycin - [**2144-10-17**] 08:39 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-17**] 10:25 PM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-18**] 06:10 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.9
C (102
   Tcurrent: 37.1
C (98.8
   HR: 62 (53 - 98) bpm
   BP: 94/48(59) {84/42(56) - 115/80(85)} mmHg
   RR: 21 (13 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 2 (2 - 12)mmHg
   Total In:
                                                                 11,160 mL
                                                                    272 mL
   PO:
                                                                  1,490 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  5,170 mL
                                                                    152 mL
   Blood products:
   Total out:
                                                                  6,445 mL
                                                                    890 mL
   Urine:
                                                                  5,445 mL
                                                                    890 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,715 mL
                                                                   -618 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: 7.42/34/32/22/-2
   Physical Examination
   VS: T97.3 HR 69 BP 84/53 RR 24  100% RA
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   65 K/uL
   10.0 g/dL
   130 mg/dL
   0.8 mg/dL
   22 mEq/L
   4.0 mEq/L
   7 mg/dL
   113 mEq/L
   141 mEq/L
   29.5 %
   5.0 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
   WBC
   4.2
   4.1
   5.0
   Hct
   29.6
   28.0
   29.5
   Plt
   58
   60
   65
   Cr
   0.7
   0.7
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:8.3 mg/dL, Mg++:2.4 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.
   -nasal aspirate for influenza
   -continue antibiotics to cover for staph/strep,
   -f/u ID reccs
   -continue vancomycin given recent IV drug use, infuse slowly given
   concern for h/o red man syndrome
   -zosyn x24 hours, d/c if culutures negative
   -f/u cultures
   -consider echo for endocarditis if continues to have fevers or if blood
   cultures positive
   -tylenol/motrin prn
   -send ABG
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65
   -continue IVF to maintain CVP 8-10
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeing.
   -monitor PLT, coags
   -consider DIC if worsening but unlikely at this time
   -send DIC labs
   .
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Started Daptomycin per ID recs
   Checking cyptococcus, lyme, CMV
   TTE ordered
   Got IVF in attempts to wean pressors, able to wean Levo to 0.04
   Got Clonazepam 1mg X 1 at night for anxiety
 MULTI LUMEN - START [**2144-10-17**] 08:15 AM
 FEVER - 102.0
F - [**2144-10-17**] 10:46 PM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Daptomycin - [**2144-10-17**] 08:39 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-17**] 10:25 PM
   Infusions:
   Norepinephrine - 0.04 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-18**] 06:10 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.9
C (102
   Tcurrent: 37.1
C (98.8
   HR: 62 (53 - 98) bpm
   BP: 94/48(59) {84/42(56) - 115/80(85)} mmHg
   RR: 21 (13 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 2 (2 - 12)mmHg
   Total In:
                                                                 11,160 mL
                                                                    272 mL
   PO:
                                                                  1,490 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  5,170 mL
                                                                    152 mL
   Blood products:
   Total out:
                                                                  6,445 mL
                                                                    890 mL
   Urine:
                                                                  5,445 mL
                                                                    890 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  4,715 mL
                                                                   -618 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: 7.42/34/32/22/-2
   Physical Examination
   VS: T97.3 HR 69 BP 84/53 RR 24  100% RA
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   65 K/uL
   10.0 g/dL
   130 mg/dL
   0.8 mg/dL
   22 mEq/L
   4.0 mEq/L
   7 mg/dL
   113 mEq/L
   141 mEq/L
   29.5 %
   5.0 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
   WBC
   4.2
   4.1
   5.0
   Hct
   29.6
   28.0
   29.5
   Plt
   58
   60
   65
   Cr
   0.7
   0.7
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:8.3 mg/dL, Mg++:2.4 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.
   -nasal aspirate for influenza
   -continue antibiotics to cover for staph/strep,
   -f/u ID reccs
   -continue vancomycin given recent IV drug use, infuse slowly given
   concern for h/o red man syndrome
   -zosyn x24 hours, d/c if culutures negative
   -f/u cultures
   -consider echo for endocarditis if continues to have fevers or if blood
   cultures positive
   -tylenol/motrin prn
   -send ABG
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65
   -continue IVF to maintain CVP 8-10
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeing.
   -monitor PLT, coags
   -consider DIC if worsening but unlikely at this time
   -send DIC labs
   .
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 48-year-old male with HIV and HCV who was admitted to the ICU with fevers and hypotension, concerning for sepsis. He has a history of injection drug use and recent crystal meth use. He has been treated with antibiotics to cover for staph/strep infections, and vancomycin has been continued given his history of IV drug use. His vital signs are stable, with a temperature of 98.8°C, heart rate of 69 bpm, and blood pressure of 84/53 mmHg. His respiratory support includes oxygen delivery at 99% saturation.

The patient's laboratory results show thrombocytopenia, coagulopathy, and anemia, which are likely related to acute sepsis. His liver function tests are abnormal, with elevated ALT and AST levels. His blood cultures are pending.

The patient's plan includes continuing antibiotics to cover for staph/strep infections, and considering an echocardiogram if he continues to have fevers or if blood cultures are positive. He will also receive antiretroviral therapy for his HIV and HCV infections.

Potential medical complications:

1. Sepsis: The patient's fevers and hypotension are concerning for sepsis, which can lead to multi-organ dysfunction and death if not treated promptly and effectively.
2. Endocarditis: The patient's history of injection drug use and recent crystal meth use increase his risk of developing endocarditis, which can lead to serious complications if not treated promptly and effectively.
3. Thrombocytopenia: The patient's thrombocytopenia can increase his risk of bleeding, particularly if he is taking anticoagulant therapy.
4. Coagulopathy: The patient's coagulopathy can increase his risk of bleeding, particularly if he is taking anticoagulant therapy.
5. Anemia: The patient's anemia can increase his risk of fatigue, shortness of breath, and decreased exercise tolerance.
6. Liver dysfunction: The patient's abnormal liver function tests can increase his risk of liver failure and death.
7. HIV/HCV: The patient's HIV and HCV infections can increase his risk of opportunistic infections and liver disease if not treated promptly and effectively.
8. Renal dysfunction: The patient's abnormal blood urea nitrogen and creatinine levels can increase his risk of renal failure and death."
116626.0,290736,2144-10-19 05:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Following cultures: CMV, Flu, Legionella, and Lyme
   - TTE ordered but not yet complete
   - Started on clindamycin per ID recs as an anti-toxin [**Doctor Last Name **].
   - [**Last Name (un) 567**]-Stim: 12.2 - 32.1 - 35.9
   - Following bacterial cultures
   - Follow coags in the AM.
   - Had persistent hypotension, refractory to fluid resuscition, and was
   started on Levophed and pan cultured.
   - Started having a new rash.
   - Subsequently, stopped clindamycin and sent a tryptase send out lab.
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-19**] 05:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 38.4
C (101.1
   HR: 89 (61 - 89) bpm
   BP: 91/49(59) {79/40(50) - 118/74(86)} mmHg
   RR: 22 (16 - 26) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 8 (0 - 17)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,225 mL
   PO:
                                                                  1,390 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,105 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    210 mL
   Urine:
                                                                  4,240 mL
                                                                    210 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                  1,015 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   49 K/uL
   8.6 g/dL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
 HEART BLOCK, COMPLETE (CHB)
 SHOCK, SEPTIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Following cultures: CMV, Flu, Legionella, and Lyme
   - TTE ordered but not yet complete
   - Started on clindamycin per ID recs as an anti-toxin [**Doctor Last Name **].
   - [**Last Name (un) 567**]-Stim: 12.2 - 32.1 - 35.9
   - Following bacterial cultures
   - Follow coags in the AM.
   - Had persistent hypotension, refractory to fluid resuscition, and was
   started on Levophed and pan cultured.
   - Started having a new rash.
   - Subsequently, stopped clindamycin and sent a tryptase send out lab.
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-19**] 05:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 38.4
C (101.1
   HR: 89 (61 - 89) bpm
   BP: 91/49(59) {79/40(50) - 118/74(86)} mmHg
   RR: 22 (16 - 26) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 8 (0 - 17)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,225 mL
   PO:
                                                                  1,390 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,105 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    210 mL
   Urine:
                                                                  4,240 mL
                                                                    210 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                  1,015 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///21/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   49 K/uL
   8.6 g/dL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
 HEART BLOCK, COMPLETE (CHB)
 SHOCK, SEPTIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 24-year-old individual admitted to the ICU with a chief complaint of fever and hypotension. They have a history of allergic reactions to vancomycin and a rash. The patient's vital signs are unstable, with a temperature of 101.1°F, heart rate of 89 bpm, and blood pressure of 91/49 mmHg. They are receiving treatment with clindamycin, levophed, and pan-culture. The patient's laboratory results show leukocytosis, thrombocytopenia, and elevated lactate levels. They have a tryptase level sent out for evaluation.

Potential Medical Complications:

1. Septic Shock: The patient's hypotension and fever are concerning for septic shock, which can lead to organ dysfunction and death if not treated promptly.
2. Cardiac Arrest: The patient's heart block, complete (CHB) and refractory hypotension increase the risk of cardiac arrest.
3. Renal Failure: The patient's elevated lactate levels and hypotension may indicate impending renal failure.
4. Respiratory Failure: The patient's abnormal ABG results and need for oxygen therapy suggest respiratory failure.
5. Sepsis-Induced Coagulopathy: The patient's thrombocytopenia and elevated D-dimer levels may indicate sepsis-induced coagulopathy, which can lead to bleeding and organ dysfunction.
6. Allergic Reaction: The patient's history of allergic reactions to vancomycin and the development of a rash while receiving clindamycin increase the risk of an allergic reaction to other medications.
7. Multi-Organ Dysfunction Syndrome (MODS): The patient's unstable vital signs, laboratory results, and clinical presentation suggest the possibility of MODS, which can lead to a poor prognosis.

Recommendations:

1. Continue to monitor the patient's vital signs and laboratory results closely.
2. Administer antibiotics and antifungals as indicated by the patient's cultures and clinical presentation.
3. Consider adding vasopressors and inotropes to support the patient's blood pressure and cardiac function.
4. Monitor the patient's renal function and consider initiating renal replacement therapy if necessary.
5. Continue to provide oxygen therapy and consider intubation if the patient's respiratory status worsens.
6. Consider consulting with an allergist or immunologist to evaluate the patient's allergic reactions and develop a plan for future medication administration.
7. Consider consulting with a cardiologist to evaluate the patient's cardiac status and develop a plan for cardiac management."
116626.0,290736,2144-10-19 05:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Following cultures: CMV, Flu, Legionella, and [** **]
   - TTE ordered but not yet complete
   - Started on clindamycin per ID recs as an anti-toxin [**Doctor Last Name **].
   - [**Last Name (un) 567**]-Stim: 12.2 - 32.1 - 35.9
   - Following bacterial cultures
   - Follow coags in the AM.
   - Had persistent hypotension, refractory to fluid resuscition, and was
   started on Levophed and pan cultured.
   - Started having a new rash.
   - Subsequently, stopped clindamycin and sent a tryptase send out lab.
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-19**] 05:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 38.4
C (101.1
   HR: 89 (61 - 89) bpm
   BP: 91/49(59) {79/40(50) - 118/74(86)} mmHg
   RR: 22 (16 - 26) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 8 (0 - 17)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,225 mL
   PO:
                                                                  1,390 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,105 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    210 mL
   Urine:
                                                                  4,240 mL
                                                                    210 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                  1,015 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   49 K/uL
   8.6 g/dL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.  Given ECG conduction
   problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin and Zosyn, add Clinda per ID recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10
   - [**Last Name (un) **] stim test today
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeding. DIC labs negative.
   -monitor PLT, coags
   ..
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Following cultures: CMV, Flu, Legionella, and [** **]
   - TTE ordered but not yet complete
   - Started on clindamycin per ID recs as an anti-toxin [**Doctor Last Name **].
   - [**Last Name (un) 567**]-Stim: 12.2 - 32.1 - 35.9
   - Following bacterial cultures
   - Follow coags in the AM.
   - Had persistent hypotension, refractory to fluid resuscition, and was
   started on Levophed and pan cultured.
   - Started having a new rash.
   - Subsequently, stopped clindamycin and sent a tryptase send out lab.
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-19**] 05:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 38.4
C (101.1
   HR: 89 (61 - 89) bpm
   BP: 91/49(59) {79/40(50) - 118/74(86)} mmHg
   RR: 22 (16 - 26) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 8 (0 - 17)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,225 mL
   PO:
                                                                  1,390 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,105 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    210 mL
   Urine:
                                                                  4,240 mL
                                                                    210 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                  1,015 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions
   Neck: right IJ in place
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, no rash no concerning lesions, slight erythema, no
   induration at site of L antecubital fossa where he recently injected
   crystal meth
   Labs / Radiology
   49 K/uL
   8.6 g/dL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:14.6/40.4/1.3, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia other likely source would
   be viral respiratory infection, PNA less likely given clear CXR. LP
   without evidence of meningitis, UA negative.  Given ECG conduction
   problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin and Zosyn, add Clinda per ID recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10
   - [**Last Name (un) **] stim test today
   .
   #Thrombocytopenia, coagulopathy - new compared with baseline, likely
   [**1-11**] acute sepsis.  No current evidence of bleeding. DIC labs negative.
   -monitor PLT, coags
   ..
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient, a 48-year-old male with HIV and HCV, is being treated in the ICU for fevers, hypotension, and sepsis. He has a history of injection drug use, which may be related to his current condition. He has been receiving antibiotics, including clindamycin, which was stopped due to a rash. He is also receiving levophed to support his blood pressure. His laboratory results show thrombocytopenia, coagulopathy, and anemia, which may be related to his sepsis. He has a tryptase level pending to evaluate for an allergic reaction to clindamycin.

Potential Medical Complications:

1. Sepsis: The patient's fevers, hypotension, and laboratory results suggest sepsis. This condition can lead to organ failure, including renal, respiratory, and cardiovascular failure.
2. Thrombocytopenia: The patient's low platelet count may increase his risk of bleeding, particularly if he requires invasive procedures or surgery.
3. Coagulopathy: The patient's coagulopathy may increase his risk of bleeding and thrombosis.
4. Anemia: The patient's anemia may worsen his overall condition and increase his risk of bleeding.
5. Allergic reaction: The patient's rash and tryptase level pending may indicate an allergic reaction to clindamycin, which could lead to anaphylaxis or other severe allergic reactions.
6. Myocarditis: The patient's ECG conduction problems and laboratory results suggest myocarditis, which could lead to cardiac arrhythmias, heart failure, or even death.
7. Liver disease: The patient's liver enzymes are elevated, which may indicate liver damage or disease. This could lead to liver failure, jaundice, or other complications.
8. Kidney disease: The patient's laboratory results show elevated creatinine levels, which may indicate kidney damage or disease. This could lead to kidney failure, acidosis, or other complications.
9. Respiratory failure: The patient's respiratory status is stable, but his laboratory results show elevated lactate levels, which may indicate respiratory failure or acidosis.
10. Infection: The patient's laboratory results show elevated white blood cell count and C-reactive protein, which may indicate infection. This could lead to sepsis, organ failure, or death."
116626.0,290736,2144-10-19 05:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Following cultures: CMV, Flu, Legionella, and [** **]
   - TTE ordered but not yet performed
   - Started on clindamycin per ID recs as an anti-toxin [**Doctor Last Name **].
   - [**Last Name (un) 567**]-Stim: 12.2 - 32.1 - 35.9
 normal
   - Following bacterial cultures- negative thus far
   - Follow coags in the AM.
   - Had persistent hypotension, refractory to fluid resuscition, and was
   started on .Levophed and pan cultured.
   - Started having a new rash.
   - Subsequently, stopped clindamycin and sent a tryptase send out lab.
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-19**] 05:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 38.4
C (101.1
   HR: 89 (61 - 89) bpm
   BP: 91/49(59) {79/40(50) - 118/74(86)} mmHg
   RR: 22 (16 - 26) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 8 (0 - 17)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,225 mL
   PO:
                                                                  1,390 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,105 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    210 mL
   Urine:
                                                                  4,240 mL
                                                                    210 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                  1,015 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   sparing shoulders and face, involving buttocks and thighs.
   Labs / Radiology
   49 K/uL
   8.6 g/dL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
   U/A- [**5-19**] WB, >50 RBCs
   Micro- [**10-17**] sputum- 2+ GPC, 2+ GNR
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:13.3/97.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative agents.  Fever,
   hypotension, and rash would be concerning for a toxic-shock syndrome
   picture, but again, patient would be likely culture positive.  Other
   likely sources would be viral respiratory infection, PNA less likely
   given clear CXR. LP without evidence of meningitis.  U/A is positive,
   representing possible UTI, pyelonephritis, or spillover of infection
   from the bloodstream.  However, this would be covered by antibiotics.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin because of vanco allergy, Zosyn, add Clinda per ID
   recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome much less likely.  No ocular/mucous membrane involvement
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**].
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.
   -          If skin grows painful, or eyes/mouth become involved, derm
   consult
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Following cultures: CMV, Flu, Legionella, and [** **]
   - TTE ordered but not yet performed
   - Started on clindamycin per ID recs as an anti-toxin [**Doctor Last Name **].
   - [**Last Name (un) 567**]-Stim: 12.2 - 32.1 - 35.9
 normal
   - Following bacterial cultures- negative thus far
   - Follow coags in the AM.
   - Had persistent hypotension, refractory to fluid resuscition, and was
   started on .Levophed and pan cultured.
   - Started having a new rash.
   - Subsequently, stopped clindamycin and sent a tryptase send out lab.
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-19**] 05:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 38.4
C (101.1
   HR: 89 (61 - 89) bpm
   BP: 91/49(59) {79/40(50) - 118/74(86)} mmHg
   RR: 22 (16 - 26) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 8 (0 - 17)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,225 mL
   PO:
                                                                  1,390 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,105 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    210 mL
   Urine:
                                                                  4,240 mL
                                                                    210 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                  1,015 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   sparing shoulders and face, involving buttocks and thighs.
   Labs / Radiology
   49 K/uL
   8.6 g/dL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
   U/A- [**5-19**] WB, >50 RBCs
   Micro- [**10-17**] sputum- 2+ GPC, 2+ GNR
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:13.3/97.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative agents.  Fever,
   hypotension, and rash would be concerning for a toxic-shock syndrome
   picture, but again, patient would be likely culture positive.  Other
   likely sources would be viral respiratory infection, PNA less likely
   given clear CXR. LP without evidence of meningitis.  U/A is positive,
   representing possible UTI, pyelonephritis, or spillover of infection
   from the bloodstream.  However, this would be covered by antibiotics.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin because of vanco allergy, Zosyn, add Clinda per ID
   recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome much less likely.  No ocular/mucous membrane involvement
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**].
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.
   -          If skin grows painful, or eyes/mouth become involved, derm
   consult
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 48-year-old male with HIV and HCV who was admitted to the ICU with fevers, hypotension, and a rash. He has a history of injection drug use and has received antibiotics for suspected bacteremia/endocarditis. The patient's fever, hypotension, and rash are concerning for toxic-shock syndrome, but he is likely to be culture-positive. The patient has also been diagnosed with anemia, thrombocytopenia, and coagulopathy. He is receiving treatment for his conditions, including antibiotics, antivirals, and blood transfusions.

Potential Medical Complications:

1. Sepsis: The patient's fever, hypotension, and rash are concerning for sepsis, which can lead to organ dysfunction and death.
2. Toxic-Shock Syndrome: The patient's symptoms are also concerning for toxic-shock syndrome, which can be life-threatening if not treated promptly.
3. Endocarditis: The patient's history of injection drug use and bacteremia/endocarditis diagnosis increase his risk for endocarditis, which can lead to heart failure and death.
4. Anemia: The patient's anemia may worsen if he continues to experience bleeding or if his underlying condition is not adequately treated.
5. Thrombocytopenia: The patient's thrombocytopenia may increase his risk for bleeding, especially if he experiences trauma or undergoes invasive procedures.
6. Coagulopathy: The patient's coagulopathy may increase his risk for bleeding, especially if he experiences trauma or undergoes invasive procedures.
7. Liver Disease: The patient's liver disease may worsen if he continues to experience liver damage or if his underlying condition is not adequately treated.
8. Kidney Disease: The patient's kidney disease may worsen if he continues to experience kidney damage or if his underlying condition is not adequately treated.
9. Respiratory Failure: The patient's respiratory failure may worsen if he continues to experience respiratory distress or if his underlying condition is not adequately treated.
10. Cardiac Arrest: The patient's cardiac arrest may occur if he experiences a sudden drop in blood pressure or if his underlying condition is not adequately treated.

Recommendations:

1. Continue to monitor the patient's vital signs and lab results closely to detect any changes in his condition.
2. Continue to treat the patient's underlying conditions, including antibiotics, antivirals, and blood transfusions.
3. Consider consulting with a dermatologist to evaluate the patient's rash and determine the best course of treatment.
4. Consider consulting with a cardiologist to evaluate the patient's cardiac function and determine the best course of treatment.
5. Consider consulting with a nephrologist to evaluate the patient's kidney function and determine the best course of treatment.
6. Consider consulting with a pulmonologist to evaluate the patient's respiratory function and determine the best course of treatment.
7. Consider consulting with a hematologist to evaluate the patient's blood count and determine the best course of treatment."
116626.0,290736,2144-10-19 11:38:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 BLOOD CULTURED - At [**2144-10-19**] 04:30 AM
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   -Levophed restarted overnight
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 09:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Respiratory: Tachypnea
   Heme / Lymph: Anemia
   Flowsheet Data as of  [**2144-10-19**] 11:25 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 37.4
C (99.4
   HR: 82 (60 - 91) bpm
   BP: 103/57(65) {68/30(41) - 135/74(86)} mmHg
   RR: 22 (16 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
   CVP: 8 (0 - 18)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,814 mL
   PO:
                                                                  1,390 mL
                                                                    520 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,294 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    850 mL
   Urine:
                                                                  4,240 mL
                                                                    850 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                    964 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///21/
   Physical Examination
   General Appearance: Thin
   Cardiovascular: (S1: Absent), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Diminished: )
   Skin:  Not assessed, Rash: Diffuse and intense coalescent erythematous
   rash dominant on trunk
back and front with mild involvement in proximal
   LE medially.
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   8.6 g/dL
   49 K/uL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Fluid analysis / Other labs: AG-8
   Imaging: CXR-[**2144-10-19**]
   Elevated right diaphragm
   right IJ in proximal RA
   Microbiology: Sputum-2+ GPC's and 2+ GNR's
   Assessment and Plan
   48 yo male with history of HIV and Hep C now admit with sepsis and
   significant hypotension now with antibiotics maintained and transient
   discontinuation of levophed has had recurrent fever and hypotension
   requiring return of pressor suppport.  He has wide range of
   differential diagnosis in terms of possible sources of continued fever
   and sepsis requiring pressor support in the setting of
   immunosupression.
 HEART BLOCK, COMPLETE (CHB)
 SHOCK, SEPTIC
   -Daptomycin/Zosyn
   -Persistent compromise raises the issue of possible treatment failure
   and/or TSS has been raised
   -Clinda added for TSS x 48 hours
   -Favor addition of Levofloxacin for possible atypical bacterial
   -ECHO today
   -Wean Levophed as possible today, IVF bolus as needed
   HIV-
   -Meds continued per ID suggestion
   RASH-Signifiant eruption in the past 24 hours and in the setting of
   recurrent hypotension
   -Unclear as to source
   -No evidence of mucosal infection
   -No bullae
   -Possible Vanco reaction but is atypical in timing and pattern
   -Derm consult if persistent
   THROMBOCYTOPENIA-
   -Stable and low
   -Heparin held
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition :ICU
   Total time spent: 45 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 BLOOD CULTURED - At [**2144-10-19**] 04:30 AM
 FEVER - 101.1
F - [**2144-10-19**] 03:45 AM
   -Levophed restarted overnight
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-18**] 07:00 AM
   Daptomycin - [**2144-10-18**] 08:00 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-19**] 09:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Respiratory: Tachypnea
   Heme / Lymph: Anemia
   Flowsheet Data as of  [**2144-10-19**] 11:25 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.4
C (101.1
   Tcurrent: 37.4
C (99.4
   HR: 82 (60 - 91) bpm
   BP: 103/57(65) {68/30(41) - 135/74(86)} mmHg
   RR: 22 (16 - 27) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
   CVP: 8 (0 - 18)mmHg
   Total In:
                                                                  4,067 mL
                                                                  1,814 mL
   PO:
                                                                  1,390 mL
                                                                    520 mL
   TF:
   IVF:
                                                                  2,677 mL
                                                                  1,294 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    850 mL
   Urine:
                                                                  4,240 mL
                                                                    850 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -173 mL
                                                                    964 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///21/
   Physical Examination
   General Appearance: Thin
   Cardiovascular: (S1: Absent), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Diminished: )
   Skin:  Not assessed, Rash: Diffuse and intense coalescent erythematous
   rash dominant on trunk
back and front with mild involvement in proximal
   LE medially.
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   8.6 g/dL
   49 K/uL
   93 mg/dL
   0.8 mg/dL
   21 mEq/L
   3.4 mEq/L
   11 mg/dL
   110 mEq/L
   139 mEq/L
   25.5 %
   3.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   Hct
   29.6
   28.0
   29.5
   25.5
   Plt
   58
   60
   65
   49
   Cr
   0.7
   0.7
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.7 mg/dL, Mg++:1.8 mg/dL, PO4:2.4 mg/dL
   Fluid analysis / Other labs: AG-8
   Imaging: CXR-[**2144-10-19**]
   Elevated right diaphragm
   right IJ in proximal RA
   Microbiology: Sputum-2+ GPC's and 2+ GNR's
   Assessment and Plan
   48 yo male with history of HIV and Hep C now admit with sepsis and
   significant hypotension now with antibiotics maintained and transient
   discontinuation of levophed has had recurrent fever and hypotension
   requiring return of pressor suppport.  He has wide range of
   differential diagnosis in terms of possible sources of continued fever
   and sepsis requiring pressor support in the setting of
   immunosupression.
 HEART BLOCK, COMPLETE (CHB)
 SHOCK, SEPTIC
   -Daptomycin/Zosyn
   -Persistent compromise raises the issue of possible treatment failure
   and/or TSS has been raised
   -Clinda added for TSS x 48 hours
   -Favor addition of Levofloxacin for possible atypical bacterial
   -ECHO today
   -Wean Levophed as possible today, IVF bolus as needed
   HIV-
   -Meds continued per ID suggestion
   RASH-Signifiant eruption in the past 24 hours and in the setting of
   recurrent hypotension
   -Unclear as to source
   -No evidence of mucosal infection
   -No bullae
   -Possible Vanco reaction but is atypical in timing and pattern
   -Derm consult if persistent
   THROMBOCYTOPENIA-
   -Stable and low
   -Heparin held
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-17**] 08:15 AM
   20 Gauge - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition :ICU
   Total time spent: 45 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 48-year-old male with a history of HIV and Hep C, admitted with sepsis and significant hypotension. The patient has been receiving antibiotics and pressor support, including levophed, which was temporarily discontinued due to recurrent fever and hypotension. The patient has developed a diffuse and intense coalescent erythematous rash on the trunk, back, and front, with mild involvement in proximal LE medially.

The patient's vital signs are:

* Temperature: 101.1°F (38.4°C)
* Heart rate: 82 beats per minute (bpm)
* Blood pressure: 103/57 mmHg
* Respiratory rate: 22 breaths per minute
* Oxygen saturation: 100%

The patient's laboratory results show:

* White blood cell count: 4.2-5.0 x 10^9/L
* Hemoglobin: 8.6 g/dL
* Platelet count: 58-65 x 10^9/L
* Creatinine: 0.7-0.8 mg/dL
* Blood urea nitrogen: 21-25.5 mg/dL
* Glucose: 104-130 mg/dL
* Lactic acid: 1.7 mmol/L
* LDH: 200 IU/L
* Calcium: 7.7 mg/dL
* Magnesium: 1.8 mg/dL
* Phosphorus: 2.4 mg/dL

The patient's imaging studies show:

* Chest X-ray: Elevated right diaphragm and right IJ in proximal RA
* ECHO: Not performed

The patient's medical history includes:

* HIV
* Hep C
* History of sepsis and hypotension

The patient's medications include:

* Antibiotics: Vancomycin, Piperacillin/Tazobactam (Zosyn), Daptomycin, Clindamycin
* Pressor support: Levophed
* HIV medications: Not specified
* Other medications: Not specified

Potential medical complications that may arise based on this information include:

* Sepsis-related organ dysfunction (e.g., acute kidney injury, respiratory failure)
* Septic shock
* Heart block (complete)
* Thrombocytopenia
* TSS (toxic shock syndrome)
* Vancomycin reaction
* HIV-related complications (e.g., opportunistic infections, immune reconstitution inflammatory syndrome)
* Hep C-related complications (e.g., liver failure, cirrhosis)

Based on the patient's clinical presentation and laboratory results, the patient's condition is likely to continue to require close monitoring and management in the ICU."
116626.0,290736,2144-10-20 06:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   -          Rash- Most likely drug rash, followed by viral exanthem, and
   toxic shock syndrome.  No ocular/mucous membrane involvement or skin
   pain concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  Zosyn is an unusual source of rash (2.3-5%).  HIV-associated
   erythrodermic rashes include drug reaction, hypereosinophilic syndrome,
   pityriasis rubra pilaris, and severe psoriasis.  The latter two would
   exhibit more epidermal and keratotic changes.  Finally, other HIV
   medications are capable of causing rashes, but he has been on these
   agents in the past.
   -          Derm consult as above.
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax to decrease sedation.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   -          Rash- Most likely drug rash, followed by viral exanthem, and
   toxic shock syndrome.  No ocular/mucous membrane involvement or skin
   pain concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  Zosyn is an unusual source of rash (2.3-5%).  HIV-associated
   erythrodermic rashes include drug reaction, hypereosinophilic syndrome,
   pityriasis rubra pilaris, and severe psoriasis.  The latter two would
   exhibit more epidermal and keratotic changes.  Finally, other HIV
   medications are capable of causing rashes, but he has been on these
   agents in the past.
   -          Derm consult as above.
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax to decrease sedation.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 48-year-old male with HIV and HCV who is presenting with fevers, hypotension, and worsening rash. The patient's condition is concerning for sepsis, and the differential diagnosis includes bacteremia/endocarditis, viral infection or reactivation, histoplasmosis, and syphilis.

The patient has received various antibiotics, including vancomycin, piperacillin-tazobactam, and daptomycin, due to a vancomycin allergy. The patient's rash is most likely related to a drug reaction, with a possibility of toxic shock syndrome or histoplasmosis. The patient's platelet count is low, and the patient is at risk for bleeding.

The patient's laboratory results show anemia, thrombocytopenia, and coagulopathy. The patient's creatinine and blood urea nitrogen levels are elevated, indicating kidney dysfunction. The patient's liver function tests are abnormal, indicating liver dysfunction.

The patient's vital signs are as follows:

* Temperature: 102.2°F (39°C)
* Heart rate: 88 beats per minute
* Blood pressure: 105/60 mmHg
* Respiratory rate: 28 breaths per minute
* Oxygen saturation: 99%

The patient's physical examination shows a diffuse, blanching, erythematous rash on the trunk and back, with slight morbiliform pattern on the chest. The patient has a mild rash on the thighs and buttocks.

The patient's assessment and plan include:

* Continuing antibiotics, including daptomycin and piperacillin-tazobactam
* Monitoring the patient's platelet count and coagulation status
* Transfusing platelets and coagulation factors if necessary
* Continuing IV fluids to maintain a central venous pressure of 8-10 mmHg
* Monitoring the patient's liver function tests and adjusting treatment as necessary
* Considering induced sputum for PCP if the patient's respiratory status worsens
* Ordering differential on the complete blood count to look for eosinophilia to support a drug reaction

The patient's potential medical complications include:

* Sepsis
* Bacteremia/endocarditis
* Viral infection or reactivation
* Histoplasmosis
* Syphilis
* Toxic shock syndrome
* Liver dysfunction
* Kidney dysfunction
* Bleeding due to thrombocytopenia
* Coagulopathy

The patient's social worker has been consulted for addiction treatment, and the patient's code status is full."
116626.0,290736,2144-10-20 06:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Greater involvement of buttocks and thighs.  No exfoliation,, no oral
   crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens.  Fever,
   hypotension, and rash would be concerning for a toxic-shock syndrome
   picture, but again, patient would be likely culture positive.  Other
   likely sources would be viral respiratory infection, PNA less likely
   given clear CXR. LP without evidence of meningitis.  U/A is positive,
   representing possible UTI, pyelonephritis, or spillover of infection
   from the bloodstream.  However, this would be covered by antibiotics.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin because of vanco allergy, Zosyn, add Clinda per ID
   recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome much less likely.  No ocular/mucous membrane involvement
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**].
   -          Recheck diff for eosinophilia
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.
   -          If skin grows painful, or eyes/mouth become involved, derm
   consult
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Greater involvement of buttocks and thighs.  No exfoliation,, no oral
   crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens.  Fever,
   hypotension, and rash would be concerning for a toxic-shock syndrome
   picture, but again, patient would be likely culture positive.  Other
   likely sources would be viral respiratory infection, PNA less likely
   given clear CXR. LP without evidence of meningitis.  U/A is positive,
   representing possible UTI, pyelonephritis, or spillover of infection
   from the bloodstream.  However, this would be covered by antibiotics.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin because of vanco allergy, Zosyn, add Clinda per ID
   recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome much less likely.  No ocular/mucous membrane involvement
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**].
   -          Recheck diff for eosinophilia
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.
   -          If skin grows painful, or eyes/mouth become involved, derm
   consult
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 48-year-old male with HIV and HCV who is currently in the ICU due to fevers, hypotension, and worsening rash. The patient's condition is concerning for sepsis, and the source of infection is unclear. The patient has a history of recent injection drug use, which may be contributing to bacteremia or endocarditis.

The patient's laboratory results show leukocytosis, thrombocytopenia, and coagulopathy. The patient's liver function tests (LFTs) are elevated, and the patient has a history of liver disease.

The patient's medical history includes HIV and HCV, and the patient is currently receiving antiretroviral therapy (ART) and interferon/ribaviron therapy.

The patient's current medications include:

* Levophed for blood pressure support
* Norepinephrine infusion for vasopressor support
* Azithromycin for atypical coverage
* Daptomycin for bacteremia/endocarditis
* Piperacillin/tazobactam (Zosyn) for coverage of potential pathogens
* Clindamycin for coverage of potential pathogens
* Tylenol and Ibuprofen for fever control
* Sarna lotion and diphenhydramine for symptomatic relief of rash

The patient's plan of care includes:

* Continuing antibiotics for sepsis
* Monitoring of platelet count and coagulation studies
* Transfusion of blood products if necessary
* Monitoring of liver function tests
* Holding off on ribaviron therapy for now
* Continuing antiretroviral therapy
* Monitoring of blood pressure and vasopressor support
* Monitoring of respiratory status
* Monitoring of nutritional status

Potential medical complications that may arise include:

* Sepsis and septic shock
* Bacteremia or endocarditis
* Toxic shock syndrome
* Viral respiratory infection
* Pneumonia
* Pyelonephritis
* UTI
* Coagulopathy
* Bleeding
* Liver failure
* Kidney failure

It is essential to continue monitoring the patient's condition and adjusting the plan of care as necessary to prevent or manage these potential complications."
116626.0,290736,2144-10-20 06:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome.  No ocular/mucous membrane involvement or skin pain
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  HIV-associated erythrodermic rashes include drug reaction,
   hypereosinophilic syndrome, pityriasis rubra pilaris, and severe
   psoriasis.  The latter two would exhibit more epidermal and keratotic
   changes.
   -          Recheck diff for eosinophilia
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome.  No ocular/mucous membrane involvement or skin pain
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  HIV-associated erythrodermic rashes include drug reaction,
   hypereosinophilic syndrome, pityriasis rubra pilaris, and severe
   psoriasis.  The latter two would exhibit more epidermal and keratotic
   changes.
   -          Recheck diff for eosinophilia
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress as follows:

* The patient is a 48-year-old male with HIV and HCV, admitted to the ICU with fevers, hypotension, and a worsening rash.
* The patient's temperature has been fluctuating between 102.2°F and 103°F, with a current temperature of 98.5°F.
* The patient's blood pressure is 105/60 mmHg, with a heart rate of 88 bpm, and a respiratory rate of 28 breaths per minute.
* The patient's oxygen saturation is 99%, and he is receiving noradrenaline infusion at a rate of 0.1 mcg/kg/min to maintain his blood pressure.
* The patient has a diffuse, blanching, erythematous rash on his trunk, back, buttocks, and thighs, with no exfoliation, oral crusting, or oral ulcers.
* The patient's laboratory results show anemia, thrombocytopenia, and coagulopathy, with a low platelet count and prolonged prothrombin time.
* The patient's electrolyte levels are normal, and his liver function tests are slightly elevated.
* The patient's HIV and HCV treatments have been adjusted, and he is receiving antibiotics for suspected sepsis.
* The patient's code status is full, and he is receiving ICU care, including nutrition, glycemic control, and prophylaxis for deep vein thrombosis, stress ulcer, and ventilator-associated pneumonia.

Potential medical complications that can arise from the patient's conditions include:

* Sepsis: The patient's high fever, hypotension, and worsening rash suggest sepsis, which can lead to organ dysfunction and failure.
* Toxic-shock syndrome: The patient's rash and fever may be indicative of toxic-shock syndrome, which can be life-threatening if not treated promptly.
* Thrombocytopenia: The patient's low platelet count increases the risk of bleeding, particularly with invasive procedures.
* Coagulopathy: The patient's prolonged prothrombin time increases the risk of bleeding, particularly with invasive procedures.
* Anemia: The patient's anemia may exacerbate his hypotension and increase the risk of organ dysfunction.
* HIV/HCV treatment complications: The patient's HIV and HCV treatments may cause adverse effects, such as anemia, thrombocytopenia, and liver dysfunction.
* Methamphetamine addiction: The patient's addiction to methamphetamine may complicate his treatment and increase the risk of relapse.
* Nutritional deficiencies: The patient's malnutrition may exacerbate his anemia, thrombocytopenia, and coagulopathy, and increase the risk of organ dysfunction."
116626.0,290736,2144-10-20 06:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome.  No ocular/mucous membrane involvement or skin pain
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  HIV-associated erythrodermic rashes include drug reaction,
   hypereosinophilic syndrome, pityriasis rubra pilaris, and severe
   psoriasis.  The latter two would exhibit more epidermal and keratotic
   changes.  Finally, some hematologic malignancies can present with
   erythroderma, but would not be this rapid in onset.
   -          Recheck diff for eosinophilia
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM- showed increased
   pulmonary htn, but no vegetations or marked wall motion abnormalities
   -rash worsened
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM, sent standard and fungal
   cultures
   Fever- 103 this AM
   -still on levophed, received 1.5 L NS, 1L LR
   -ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome.  No ocular/mucous membrane involvement or skin pain
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  HIV-associated erythrodermic rashes include drug reaction,
   hypereosinophilic syndrome, pityriasis rubra pilaris, and severe
   psoriasis.  The latter two would exhibit more epidermal and keratotic
   changes.  Finally, some hematologic malignancies can present with
   erythroderma, but would not be this rapid in onset.
   -          Recheck diff for eosinophilia
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health status as follows:

* The patient is a 48-year-old male with HIV and HCV who has been admitted to the ICU due to fevers and hypotension, concerning for sepsis.
* The patient has a worsening rash, which is most likely a drug rash, possibly related to the recent injection drug use.
* The patient's lab results show:
	+ Elevated WBC count
	+ Thrombocytopenia
	+ Elevated liver enzymes (ALT and AST)
	+ Elevated bilirubin
	+ Coagulopathy
	+ Anemia
* The patient's vital signs are:
	+ Fever: 102.2°F (5:45 PM) and 103°F this morning
	+ Heart rate: 88 bpm
	+ Blood pressure: 105/60 mmHg
	+ Respiratory rate: 28 breaths per minute
	+ Oxygen saturation: 99%
* The patient has been receiving various medications, including antibiotics, antivirals, and pain management medications.
* The patient's medical history includes a history of injection drug use, HIV, and HCV.
* The patient's current diagnosis includes sepsis, possible bacteremia or endocarditis, and a toxic-shock syndrome picture.

Potential medical complications that can arise from the patient's condition include:

* Sepsis-induced organ failure (e.g., respiratory, cardiac, or renal failure)
* Bacteremia or endocarditis, leading to septic shock and multi-organ failure
* Toxic-shock syndrome, which can cause multi-organ failure and death
* Coagulopathy, leading to bleeding or thrombosis
* Thrombocytopenia, leading to bleeding or increased risk of bleeding
* Anemia, leading to fatigue, shortness of breath, or decreased cardiac output
* HIV-related complications, such as opportunistic infections or malignancies
* HCV-related complications, such as liver cirrhosis or liver failure
* Drug-related complications, such as allergic reactions or interactions with other medications.

Based on the patient's condition, the following interventions are recommended:

* Continue antibiotics to cover possible bacterial infections
* Monitor the patient's vital signs and lab results closely for signs of sepsis or organ failure
* Consider additional imaging studies, such as echocardiogram or CT scan, to evaluate for possible endocarditis or other cardiac complications
* Consider consulting with infectious disease and dermatology specialists to further evaluate the patient's rash and possible underlying infections
* Monitor the patient's coagulation status and platelet count to prevent bleeding or thrombosis
* Monitor the patient's anemia and consider transfusions if necessary
* Consider social work consultation for addiction treatment and counseling
* Continue HIV and HCV treatment as recommended by the patient's ID service."
116626.0,290736,2144-10-20 06:12:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM
   -F/u ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Echo- Pulm htn, tricuspid regurg, but no vegetations or marked wall
   motion abnormalities
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Patient re-spiked to 102.2 during day, standard and fungal cultures
   sent
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   sparing shoulders and face, involving buttocks and thighs.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative agents.  Fever,
   hypotension, and rash would be concerning for a toxic-shock syndrome
   picture, but again, patient would be likely culture positive.  Other
   likely sources would be viral respiratory infection, PNA less likely
   given clear CXR. LP without evidence of meningitis.  U/A is positive,
   representing possible UTI, pyelonephritis, or spillover of infection
   from the bloodstream.  However, this would be covered by antibiotics.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin because of vanco allergy, Zosyn, add Clinda per ID
   recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome much less likely.  No ocular/mucous membrane involvement
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**].
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.
   -          If skin grows painful, or eyes/mouth become involved, derm
   consult
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM
   -F/u ID recs
   -Derm to be consulted for worsening rash; prn benadryl & sarna lotion
   ordered
   -Echo- Pulm htn, tricuspid regurg, but no vegetations or marked wall
   motion abnormalities
   -Levophed weaned during day but restarted at night; IVF boluses also
   given
   -Patient re-spiked to 102.2 during day, standard and fungal cultures
   sent
   -Azithromycin started for atypical coverage
   -[**Year (4 digits) **] serologies sent to [**Hospital3 2537**]
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 12:00 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-20**] 06:05 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39
C (102.2
   Tcurrent: 36.9
C (98.5
   HR: 88 (62 - 95) bpm
   BP: 105/60(71) {74/35(31) - 113/62(73)} mmHg
   RR: 28 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 6 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  1,164 mL
   PO:
                                                                  1,440 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,164 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                    969 mL
   Urine:
                                                                  2,880 mL
                                                                    969 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    195 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   sparing shoulders and face, involving buttocks and thighs.
   Labs / Radiology
   64 K/uL
   8.6 g/dL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concernig for sepsis.
   .
   #Fevers - unclear source for infection at this time, although recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative agents.  Fever,
   hypotension, and rash would be concerning for a toxic-shock syndrome
   picture, but again, patient would be likely culture positive.  Other
   likely sources would be viral respiratory infection, PNA less likely
   given clear CXR. LP without evidence of meningitis.  U/A is positive,
   representing possible UTI, pyelonephritis, or spillover of infection
   from the bloodstream.  However, this would be covered by antibiotics.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.
   -f/u nasal aspirate for influenza
   -continue Daptomycin because of vanco allergy, Zosyn, add Clinda per ID
   recs X 48 hours
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome much less likely.  No ocular/mucous membrane involvement
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**].
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.
   -          If skin grows painful, or eyes/mouth become involved, derm
   consult
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -hold off on ribaviron for now per Dr. [**First Name (STitle) 2482**]
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 48-year-old male with HIV and HCV who has been admitted to the ICU with fevers, hypotension, and a rash. The patient's condition is concerning for sepsis, and the differential diagnosis includes bacteremia/endocarditis, toxic-shock syndrome, viral respiratory infection, and urinary tract infection.

The patient has a history of injection drug use, which may be a contributing factor to his condition. He has also received antibiotics for syphilis and has a vancomycin allergy.

The patient's vital signs are as follows:

* Temperature: 102.2°F (39°C)
* Heart rate: 88 beats per minute
* Blood pressure: 105/60 mmHg
* Respiratory rate: 28 breaths per minute
* Oxygen saturation: 99%

The patient's physical examination reveals a diffuse, blanching, erythematous rash on the trunk, back, buttocks, and thighs, with no evidence of oral lesions or ocular involvement.

Laboratory results show:

* White blood cell count: 4.2-5.7 x 10^9/L
* Hemoglobin: 8.6-10.5 g/dL
* Platelet count: 58-64 x 10^9/L
* Creatinine: 0.7-0.8 mg/dL
* Lactic acid: 1.7 mmol/L
* LDH: 200 IU/L
* Calcium: 7.4 mg/dL
* Magnesium: 1.7 mg/dL
* Phosphate: 2.7 mg/dL

The patient's coagulation profile shows a prolonged PT and PTT, and the differential diagnosis includes primary HIV effects, drug effects, or a consumptive process/dilution.

The patient's plan of care includes:

* Continuing antibiotics for sepsis
* Monitoring for thrombocytopenia and coagulopathy
* Transfusing blood products if necessary
* Providing supportive care for fever, hypotension, and rash
* Monitoring for signs of sepsis and adjusting treatment accordingly
* Following up with ID service for further guidance on antibiotic therapy and management of HIV/HCV

Potential medical complications that may arise include:

* Sepsis and septic shock
* Endocarditis and bacteremia
* Toxic-shock syndrome
* Urinary tract infection and pyelonephritis
* Coagulopathy and bleeding
* Thrombocytopenia and bleeding
* Hepatitis B and C exacerbation
* HIV/AIDS progression
* Opportunistic infections"
116626.0,290736,2144-10-20 11:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM
   Azithro added for atypical coverage
   ECHO without evidence of vegitation
   Rash persists and has evolved to increased areas of skin
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Flowsheet Data as of  [**2144-10-20**] 11:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.5
C (103.1
   Tcurrent: 37
C (98.6
   HR: 80 (62 - 95) bpm
   BP: 104/54(65) {74/37(31) - 113/62(71)} mmHg
   RR: 26 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
   CVP: 3 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  2,448 mL
   PO:
                                                                  1,440 mL
                                                                  1,100 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,348 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                  1,739 mL
   Urine:
                                                                  2,880 mL
                                                                  1,739 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    709 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   General Appearance: Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: INcreased to lower extremities and remains warm,
   ethythematous without bullae
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   8.6 g/dL
   64 K/uL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   48 yo with history of HIV/AIDS and now with admission with sepsis now
   with persistent fevers and evolving skin rash. This may well be drug
   reaction but there is a meaninful concern for persistent infection in
   the setting of ongoing fevers and rash.
   1)Sepsis-
   -Rash to be evaluate by Dermatology
   -Add Diff to CBC
   -Continue Dapto/Zosyn
   -F/U titres and cultures
   2)Substance Abuse-
   -Addictions consult to eval patient
 HEART BLOCK, COMPLETE (CHB)
 SHOCK, SEPTIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 35 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2144-10-19**] 02:00 PM
 FEVER - 102.2
F - [**2144-10-19**] 05:45 PM
   Azithro added for atypical coverage
   ECHO without evidence of vegitation
   Rash persists and has evolved to increased areas of skin
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Vancomycin - [**2144-10-17**] 02:30 PM
   Piperacillin - [**2144-10-18**] 10:00 PM
   Daptomycin - [**2144-10-19**] 08:30 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-19**] 09:40 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Infusions:
   Norepinephrine - 0.1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Flowsheet Data as of  [**2144-10-20**] 11:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.5
C (103.1
   Tcurrent: 37
C (98.6
   HR: 80 (62 - 95) bpm
   BP: 104/54(65) {74/37(31) - 113/62(71)} mmHg
   RR: 26 (14 - 31) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
   CVP: 3 (2 - 13)mmHg
   Total In:
                                                                  4,713 mL
                                                                  2,448 mL
   PO:
                                                                  1,440 mL
                                                                  1,100 mL
   TF:
   IVF:
                                                                  3,273 mL
                                                                  1,348 mL
   Blood products:
   Total out:
                                                                  2,880 mL
                                                                  1,739 mL
   Urine:
                                                                  2,880 mL
                                                                  1,739 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,833 mL
                                                                    709 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///20/
   Physical Examination
   General Appearance: Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: INcreased to lower extremities and remains warm,
   ethythematous without bullae
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   8.6 g/dL
   64 K/uL
   100 mg/dL
   0.8 mg/dL
   20 mEq/L
   3.4 mEq/L
   10 mg/dL
   110 mEq/L
   138 mEq/L
   24.9 %
   5.7 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   Plt
   58
   60
   65
   49
   64
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:64.6 %, Lymph:31.9 %, Mono:3.4 %,
   Eos:0.1 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L, LDH:200 IU/L,
   Ca++:7.4 mg/dL, Mg++:1.7 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   48 yo with history of HIV/AIDS and now with admission with sepsis now
   with persistent fevers and evolving skin rash. This may well be drug
   reaction but there is a meaninful concern for persistent infection in
   the setting of ongoing fevers and rash.
   1)Sepsis-
   -Rash to be evaluate by Dermatology
   -Add Diff to CBC
   -Continue Dapto/Zosyn
   -F/U titres and cultures
   2)Substance Abuse-
   -Addictions consult to eval patient
 HEART BLOCK, COMPLETE (CHB)
 SHOCK, SEPTIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 35 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 48-year-old male with a history of HIV/AIDS, currently admitted with sepsis and persistent fevers and evolving skin rash. He has received multiple antibiotics, including vancomycin, piperacillin, daptomycin, and clindamycin, with no significant improvement in symptoms. The patient's vital signs are stable, with a temperature of 103.1°F, heart rate of 80 bpm, and blood pressure of 104/54 mmHg. He has a rash that has evolved to involve the lower extremities and remains warm and erythematous without bullae.

Potential Medical Complications:

1. Sepsis: The patient's persistent fevers and evolving skin rash may indicate ongoing infection, which could lead to septic shock and organ failure.
2. Drug Reaction: The patient's skin rash may be a drug reaction, which could be caused by one of the antibiotics he has received. This could lead to further complications, such as anaphylaxis or Stevens-Johnson syndrome.
3. Heart Block: The patient has a complete heart block, which could lead to cardiac arrest and death if not properly managed.
4. Septic Shock: The patient's sepsis could progress to septic shock, which could lead to multi-organ failure and death.
5. Respiratory Complications: The patient's respiratory status is stable, but he is at risk for developing respiratory complications, such as pneumonia or acute respiratory distress syndrome, due to his sepsis and potential underlying lung disease.
6. Neurological Complications: The patient's neurological status is currently stable, but he is at risk for developing neurological complications, such as sepsis-induced encephalopathy or meningitis, due to his sepsis.
7. Infectious Complications: The patient is at risk for developing additional infectious complications, such as pneumonia or urinary tract infection, due to his sepsis and potential underlying immunocompromise.
8. Gastrointestinal Complications: The patient is at risk for developing gastrointestinal complications, such as nausea, vomiting, or diarrhea, due to his sepsis and potential underlying gastrointestinal disease.

Recommendations:

1. Continue to monitor the patient's vital signs and laboratory values closely.
2. Consider adding a dermatology consult to evaluate the patient's skin rash and determine the cause.
3. Continue to administer antibiotics as prescribed, and consider adding additional antibiotics if necessary.
4. Consider adding a cardiologist consult to evaluate the patient's heart block and determine the best course of treatment.
5. Consider adding a pulmonologist consult to evaluate the patient's respiratory status and determine the best course of treatment.
6. Consider adding a neurologist consult to evaluate the patient's neurological status and determine the best course of treatment.
7. Consider adding a gastroenterologist consult to evaluate the patient's gastrointestinal status and determine the best course of treatment.
8. Consider adding a infectious disease consult to evaluate the patient's infectious status and determine the best course of treatment."
116626.0,290736,2144-10-21 05:52:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 URINE CULTURE - At [**2144-10-20**] 05:00 PM
 FEVER - 103.4
F - [**2144-10-21**] 12:00 AM
   Continues to be febrile despite Tylenol, ibuprofen
   Clinda stopped
   Levophed stopped at 1pm yesterday, BPs in 80s but lots of urine output
   Derm consulted for rash, started hydroxyzine, triamcinolone cream,
   ranitidine, sarna lotion
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Daptomycin - [**2144-10-20**] 08:00 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-20**] 10:00 PM
   Infusions:
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-21**] 05:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.7
C (103.4
   Tcurrent: 37.9
C (100.2
   HR: 86 (70 - 90) bpm
   BP: 90/54(62) {83/34(48) - 122/79(89)} mmHg
   RR: 27 (10 - 30) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 3 (3 - 10)mmHg
   Total In:
                                                                  3,964 mL
                                                                    575 mL
   PO:
                                                                  2,200 mL
                                                                    500 mL
   TF:
   IVF:
                                                                  1,764 mL
                                                                     75 mL
   Blood products:
   Total out:
                                                                  4,739 mL
                                                                  1,440 mL
   Urine:
                                                                  4,739 mL
                                                                  1,440 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -775 mL
                                                                   -865 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   63 K/uL
   8.6 g/dL
   108 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.9 mEq/L
   9 mg/dL
   105 mEq/L
   136 mEq/L
   25.4 %
   7.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
                            [**2144-10-21**]  03:48 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   7.2
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   25.4
   Plt
   58
   60
   65
   49
   64
   63
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   0.9
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   108
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:80.0 %, Band:7.0 %, Lymph:9.0 %,
   Mono:4.0 %, Eos:0.0 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L,
   LDH:200 IU/L, Ca++:7.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   -          Rash- Most likely drug rash, followed by viral exanthem, and
   toxic shock syndrome.  No ocular/mucous membrane involvement or skin
   pain concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  Zosyn is an unusual source of rash (2.3-5%).  HIV-associated
   erythrodermic rashes include drug reaction, hypereosinophilic syndrome,
   pityriasis rubra pilaris, and severe psoriasis.  The latter two would
   exhibit more epidermal and keratotic changes.  Finally, other HIV
   medications are capable of causing rashes, but he has been on these
   agents in the past.
   -          Derm consult as above.
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax to decrease sedation.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-20**] 05:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 URINE CULTURE - At [**2144-10-20**] 05:00 PM
 FEVER - 103.4
F - [**2144-10-21**] 12:00 AM
   Continues to be febrile despite Tylenol, ibuprofen
   Clinda stopped
   Levophed stopped at 1pm yesterday, BPs in 80s but lots of urine output
   Derm consulted for rash, started hydroxyzine, triamcinolone cream,
   ranitidine, sarna lotion
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Daptomycin - [**2144-10-20**] 08:00 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-20**] 10:00 PM
   Infusions:
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-21**] 05:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.7
C (103.4
   Tcurrent: 37.9
C (100.2
   HR: 86 (70 - 90) bpm
   BP: 90/54(62) {83/34(48) - 122/79(89)} mmHg
   RR: 27 (10 - 30) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 3 (3 - 10)mmHg
   Total In:
                                                                  3,964 mL
                                                                    575 mL
   PO:
                                                                  2,200 mL
                                                                    500 mL
   TF:
   IVF:
                                                                  1,764 mL
                                                                     75 mL
   Blood products:
   Total out:
                                                                  4,739 mL
                                                                  1,440 mL
   Urine:
                                                                  4,739 mL
                                                                  1,440 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -775 mL
                                                                   -865 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   63 K/uL
   8.6 g/dL
   108 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.9 mEq/L
   9 mg/dL
   105 mEq/L
   136 mEq/L
   25.4 %
   7.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
                            [**2144-10-21**]  03:48 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   7.2
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   25.4
   Plt
   58
   60
   65
   49
   64
   63
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   0.9
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   108
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:80.0 %, Band:7.0 %, Lymph:9.0 %,
   Mono:4.0 %, Eos:0.0 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L,
   LDH:200 IU/L, Ca++:7.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -f/u nasal aspirate for influenza
   -urine histo antigen
   -Repeat RPR
   -continue Daptomycin because of vanco allergy, Zosyn, d/c clindamycin
   today
   -f/u cultures, [**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.
   -continue with antibiotics
   -continue levophed with goal MAP >65, attempt to wean as tolerated
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   -          Rash- Most likely drug rash, followed by viral exanthem, and
   toxic shock syndrome.  No ocular/mucous membrane involvement or skin
   pain concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  Zosyn is an unusual source of rash (2.3-5%).  HIV-associated
   erythrodermic rashes include drug reaction, hypereosinophilic syndrome,
   pityriasis rubra pilaris, and severe psoriasis.  The latter two would
   exhibit more epidermal and keratotic changes.  Finally, other HIV
   medications are capable of causing rashes, but he has been on these
   agents in the past.
   -          Derm consult as above.
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax to decrease sedation.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribaviron therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction
   #Code Status - Full
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-20**] 05:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 48-year-old male with HIV and HCV who has been admitted to the ICU with fevers and hypotension, concerning for sepsis. He has a worsening rash, which is likely a drug rash, followed by viral exanthem, and toxic shock syndrome. The patient has a history of drug rash in response to vancomycin and has been treated with antibiotics, including daptomycin, Zosyn, and Clindamycin.

The patient's laboratory results show thrombocytopenia, coagulopathy, and anemia, which may be related to primary HIV effects, drug effects, or a consumptive process. His liver function tests are elevated, and he has been treated with Tylenol and Ibuprofen for liver disease.

The patient's respiratory status is stable, with an SpO2 of 99%. He is on Norepinephrine infusion at 0.03 mcg/Kg/min and has a CVP of 3 mmHg. His fluid balance is negative, with a total fluid output of 4,739 mL and a urine output of 1,440 mL.

The patient's skin is warm, with a diffuse, blanching, erythematous rash on his trunk and back, and new facial involvement. He has a history of crystal meth injection and may have an underlying infection, such as bacteremia or endocarditis.

Potential medical complications that can arise include:

1. Sepsis: The patient's fever and hypotension are concerning for sepsis, and he requires continued antibiotics and supportive care.
2. Toxic shock syndrome: The patient's rash and fever may be indicative of toxic shock syndrome, which requires prompt recognition and treatment.
3. Endocarditis: The patient's history of injection drug use and fever may indicate an underlying endocarditis, which requires prompt antibiotic treatment.
4. Coagulopathy: The patient's coagulopathy may increase his risk of bleeding, and he requires close monitoring of his coagulation parameters.
5. Anemia: The patient's anemia may be related to his underlying HIV infection, drug therapy, or blood loss, and he requires close monitoring of his hemoglobin levels.
6. Thrombocytopenia: The patient's thrombocytopenia may increase his risk of bleeding, and he requires close monitoring of his platelet count.
7. Liver disease: The patient's liver function tests are elevated, and he requires continued treatment with Tylenol and Ibuprofen for liver disease.
8. HIV/HCV: The patient's HIV and HCV infections require ongoing treatment and monitoring, and he requires close follow-up with his ID service.

Overall, the patient requires close monitoring and management of his sepsis, coagulopathy, anemia, thrombocytopenia, and liver disease, as well as ongoing treatment for his HIV and HCV infections."
116626.0,290736,2144-10-21 05:52:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 URINE CULTURE - At [**2144-10-20**] 05:00 PM
 FEVER - 103.4
F - [**2144-10-21**] 12:00 AM
   Continues to be febrile despite Tylenol, ibuprofen
   Clinda stopped
   Levophed stopped at 1pm yesterday, BPs in 80s but lots of urine output
   Derm consulted for rash, thought it to be drug rash.  started
   hydroxyzine, triamcinolone cream, ranitidine, sarna lotion
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Daptomycin - [**2144-10-20**] 08:00 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-20**] 10:00 PM
   Infusions:
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-21**] 05:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.7
C (103.4
   Tcurrent: 37.9
C (100.2
   HR: 86 (70 - 90) bpm
   BP: 90/54(62) {83/34(48) - 122/79(89)} mmHg
   RR: 27 (10 - 30) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 3 (3 - 10)mmHg
   Total In:
                                                                  3,964 mL
                                                                    575 mL
   PO:
                                                                  2,200 mL
                                                                    500 mL
   TF:
   IVF:
                                                                  1,764 mL
                                                                     75 mL
   Blood products:
   Total out:
                                                                  4,739 mL
                                                                  1,440 mL
   Urine:
                                                                  4,739 mL
                                                                  1,440 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -775 mL
                                                                   -865 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   63 K/uL
   8.6 g/dL
   108 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.9 mEq/L
   9 mg/dL
   105 mEq/L
   136 mEq/L
   25.4 %
   7.2 K/uL
        [image002.jpg]
   Nasal viral aspirates- negative
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
                            [**2144-10-21**]  03:48 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   7.2
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   25.4
   Plt
   58
   60
   65
   49
   64
   63
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   0.9
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   108
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:80.0 %, Band:7.0 %, Lymph:9.0 %,
   Mono:4.0 %, Eos:0.0 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L,
   LDH:200 IU/L, Ca++:7.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -Continue surveillance blood cultures
   urine histo antigen
   -f/u RPR
   -continue Daptomycin because of vanco allergy, Zosyn.  D/c antibiotics
   tomorrow
   -[**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction.  Also, check LFTs, creatinine looking for signs of DRESS
   syndrome.
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.   D/c
d levophed.
   -continue with antibiotics
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   #Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome.  No ocular/mucous membrane involvement or skin pain
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  Zosyn is an unusual source of rash (2.3-5%).  HIV-associated
   erythrodermic rashes include drug reaction, hypereosinophilic syndrome,
   pityriasis rubra pilaris, and severe psoriasis.  The latter two would
   exhibit more epidermal and keratotic changes.  Finally, other HIV
   medications are capable of causing rashes, but he has been on these
   agents in the past.
   -          Derm consult as above.
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax to decrease sedation.
   -          Continue triamcinolone cream x 2weeks per derm recs.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribavirin therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction.  Should not go home with peripheral
   IV access.
   #Code Status - Full
   #Dispo- to hospitalist service
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-20**] 05:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 URINE CULTURE - At [**2144-10-20**] 05:00 PM
 FEVER - 103.4
F - [**2144-10-21**] 12:00 AM
   Continues to be febrile despite Tylenol, ibuprofen
   Clinda stopped
   Levophed stopped at 1pm yesterday, BPs in 80s but lots of urine output
   Derm consulted for rash, thought it to be drug rash.  started
   hydroxyzine, triamcinolone cream, ranitidine, sarna lotion
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Daptomycin - [**2144-10-20**] 08:00 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-20**] 10:00 PM
   Infusions:
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2144-10-21**] 05:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.7
C (103.4
   Tcurrent: 37.9
C (100.2
   HR: 86 (70 - 90) bpm
   BP: 90/54(62) {83/34(48) - 122/79(89)} mmHg
   RR: 27 (10 - 30) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
    CVP: 3 (3 - 10)mmHg
   Total In:
                                                                  3,964 mL
                                                                    575 mL
   PO:
                                                                  2,200 mL
                                                                    500 mL
   TF:
   IVF:
                                                                  1,764 mL
                                                                     75 mL
   Blood products:
   Total out:
                                                                  4,739 mL
                                                                  1,440 mL
   Urine:
                                                                  4,739 mL
                                                                  1,440 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -775 mL
                                                                   -865 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///21/
   Physical Examination
   Gen: Awake, alert, +shaking chills, appropriate with conversation
   HEENT: NC AT, PERRL, EOMI, slight pharyngeal exudate no oral lesions.
   R IJ line placed.
   Neck: right IJ in place  Not erythematous or indurated.  No LAD
   CV: RRR s1 s2
   Lungs: CTAB
   Abd: soft, NT, ND BS+ no rebound or guarding
   Ext: no edema, warm, mild rash on thighs and buttocks., slight
   erythema, no induration at site of L antecubital fossa where he
   recently injected crystal meth
   Skin: Diffuse, blanching, erythematous rash, mostly on trunk and back,
   with slight morbiliform pattern on chest.  New facial involvement,
   Increased  involvement of buttocks and thighs.  No exfoliation,, no
   oral crusting or oral ulcers, No ocular lesions.  No tenderness to skin
   palpation.
   Labs / Radiology
   63 K/uL
   8.6 g/dL
   108 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.9 mEq/L
   9 mg/dL
   105 mEq/L
   136 mEq/L
   25.4 %
   7.2 K/uL
        [image002.jpg]
   Nasal viral aspirates- negative
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
                            [**2144-10-21**]  03:48 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   7.2
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   25.4
   Plt
   58
   60
   65
   49
   64
   63
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   0.9
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   108
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:80.0 %, Band:7.0 %, Lymph:9.0 %,
   Mono:4.0 %, Eos:0.0 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L,
   LDH:200 IU/L, Ca++:7.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Assessment and Plan
   Mr. [**Known lastname **] is a 48 yo M with HIV, HCV presenting with fevers and
   hypotension concerning for sepsis.  Now has worsening rash.
   .
   #Fevers - unclear source for infection at this time.  Ddx: recent
   injection drug use concerning for bacteremia/endocarditis, with
   differential including staph, partially treated strep (pt received
   penicillin for syphilis), or culture negative pathogens, echo TTE was
   negative for vegetations.  Fever, hypotension, and rash would be
   concerning for a toxic-shock syndrome picture, but again, patient would
   be likely culture positive.  Other potential sources would be viral
   infection or reactivation, histoplasmosis (rarely reported to cause
   diffuse erythematous rashes), and syphilis.  Of potential anatomic
   sources, PNA unlikely given clear CXR, but patient has ongoing cough.
   Given ECG conduction problems, considering [**Name (NI) **], myocarditis.  LP
   without evidence of meningitis.  U/A is positive, representing possible
   UTI, pyelonephritis, or spillover of infection from the bloodstream.
   However, this would be covered by antibiotics.  Among non-infectious
   sources, a drug fever is possible, but patient
s fever and hypotension
   preceded initiation of antibiotics.
   -Continue surveillance blood cultures
   urine histo antigen
   -f/u RPR
   -continue Daptomycin because of vanco allergy, Zosyn.  D/c antibiotics
   tomorrow
   -[**Name (NI) 2501**] serologies, C. Diff
   - Tylenol for fevers alternating with Ibuprofen for liver disease
   -Consider induced sputum for PCP if breathing worsens
   -Order differential on CBC looking for eosinophilia to support drug
   reaction.  Also, check LFTs, creatinine looking for signs of DRESS
   syndrome.
   .
   #Hypotension - concerning for sepsis given high fevers.   [**Last Name (un) 567**] stim
   test normal.  Rash may be contributing by causing vasodilation and
   decreased peripheral resistance.   D/c
d levophed.
   -continue with antibiotics
   -continue IVF to maintain CVP 8-10.
   .
   #Thrombocytopenia, coagulopathy
 Lower than baseline.  No current
   evidence of bleeding. DIC labs negative.  Ddx: primary HIV effects,
   drug (interferon, HAART) effects, or consumptive process/dilution.
   -monitor PLT, coags
   -transfuse if Hct<21, Plt<[**9-23**]
   .
   #Rash- Most likely drug rash, followed by viral exanthem, and toxic
   shock syndrome.  No ocular/mucous membrane involvement or skin pain
   concerning for  [**Doctor Last Name 2527**]-[**Location (un) 744**] syndrome/TEN.  Additionally,
   histoplasmosis can rarely present with diffuse macular rashes.  Patient
   has h/o drug rash in response to vancomycin.  Vancomycin has some
   associated rashes, (infusion related Red Man (unlikely given timing of
   rash) IgE hypersensitivity, linear IgA  bullous dermatosis) and a rare
   exfoliative dermatitis, but pt
s rash is not yet consistent with any of
   these.  Zosyn is an unusual source of rash (2.3-5%).  HIV-associated
   erythrodermic rashes include drug reaction, hypereosinophilic syndrome,
   pityriasis rubra pilaris, and severe psoriasis.  The latter two would
   exhibit more epidermal and keratotic changes.  Finally, other HIV
   medications are capable of causing rashes, but he has been on these
   agents in the past.
   -          Derm consult as above.
   -          Sarna lotion for symptomatic relief.  Diphenhydramine for
   same.  Consider switching to atarax to decrease sedation.
   -          Continue triamcinolone cream x 2weeks per derm recs.
   -          If skin grows painful, or eyes/mouth become involved,
   re-consult derm
   #HIV/HCV - followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service.  LFT's at
   baseline.
   -continue [**Doctor Last Name 817**] with kaletra and truvada
   -Per ID, patient
s HCV treatment will be placed on hold until he begins
   treatment for methamphetamine addiction.
   .
   #Anemia - per patient [**1-11**] interferon/ribavirin therapy, gets aranesp
   injestions.  No evidence of acute bleeding and HCT close to baseline.
   -monitor HCT, PLT
   #PPX: pneumoboots (hold heparin given thrombocytopenia), bowel reg if
   needed
   .
   #FEN - regular diet, replete lytes prn
   .
   #Social- SW consult for addiction.  Should not go home with peripheral
   IV access.
   #Code Status - Full
   #Dispo- to hospitalist service
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-20**] 05:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided physician's daily progress note, the patient is a 48-year-old male with HIV and HCV, presenting with fevers, hypotension, and a worsening rash. The patient has a history of injection drug use and has recently injected crystal meth. The patient's rash is diffuse, blanching, and erythematous, with involvement of the trunk, back, and buttocks.

The patient's laboratory results show:

* WBC: 7.2 K/uL
* Hct: 25.4%
* Plt: 63
* Cr: 0.9 mg/dL
* TCO2: 18
* Glucose: 108 mg/dL
* Other labs: PT/PTT/INR: 13.3/37.2/1.1, ALT/AST: 46/51, Alk Phos/T Bili: 49/0.8, Differential-Neuts: 80.0%, Band: 7.0%, Lymph: 9.0%, Mono: 4.0%, Eos: 0.0%, Fibrinogen: 309 mg/dL, Lactic Acid: 1.7 mmol/L, LDH: 200 IU/L, Ca++: 7.4 mg/dL, Mg++: 2.1 mg/dL, PO4: 2.0 mg/dL

The patient's assessment and plan include:

* Fever: unclear source for infection, differential including bacteremia/endocarditis, viral infection, reactivation, histoplasmosis, and syphilis
* Hypotension: concerning for sepsis, considering [**Name (NI) 2501**] serologies, C. Diff
* Rash: most likely drug rash, followed by viral exanthem, and toxic shock syndrome
* Thrombocytopenia: coagulopathy, considering primary HIV effects, drug effects, or consumptive process/dilution
* Anemia: per patient [**1-11**] interferon/ribavirin therapy, gets aranesp injections
* HIV/HCV: followed by Dr. [**First Name (STitle) 2482**] and Dr. [**Last Name (STitle) 2483**] of ID service
* Social: SW consult for addiction, should not go home with peripheral IV access

Potential medical complications that can arise from the patient's conditions include:

* Sepsis: due to the patient's fevers, hypotension, and worsening rash, sepsis is a possible complication
* Toxic-shock syndrome: given the patient's fever, hypotension, and rash, toxic-shock syndrome is a possible complication
* Drug fever: the patient's rash may be caused by a drug reaction, which can lead to a fever
* Coagulopathy: the patient's thrombocytopenia and coagulopathy can lead to bleeding complications
* Anemia: the patient's anemia can worsen if not treated
* HIV/HCV: the patient's HIV and HCV can lead to complications such as opportunistic infections, liver disease, and kidney disease

Based on the patient's laboratory results and clinical presentation, the patient requires close monitoring and treatment for his fevers, hypotension, and rash. The patient's antibiotics should be continued, and his blood cultures and urine histo antigen should be monitored. The patient's HIV/HCV treatment should be placed on hold until he begins treatment for methamphetamine addiction. The patient's anemia should be monitored, and he should receive aranesp injections as needed. The patient's social situation should be assessed, and he should not be discharged with peripheral IV access."
116626.0,290736,2144-10-21 12:44:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Patient with rash felt by Dermatology consult to be most likely
   medication reaction which would be consistent with our impression as
   well.
   24 Hour Events:
 URINE CULTURE - At [**2144-10-20**] 05:00 PM
 FEVER - 103.5
F - [**2144-10-21**] 06:05 AM
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Daptomycin - [**2144-10-20**] 08:00 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-21**] 06:08 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Flowsheet Data as of  [**2144-10-21**] 12:43 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.7
C (103.5
   Tcurrent: 38
C (100.4
   HR: 76 (70 - 93) bpm
   BP: 95/46(57) {83/34(48) - 112/62(68)} mmHg
   RR: 25 (10 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
   CVP: 3 (3 - 3)mmHg
   Total In:
                                                                  3,933 mL
                                                                  1,375 mL
   PO:
                                                                  2,200 mL
                                                                  1,050 mL
   TF:
   IVF:
                                                                  1,733 mL
                                                                    325 mL
   Blood products:
   Total out:
                                                                  4,739 mL
                                                                  3,315 mL
   Urine:
                                                                  4,739 mL
                                                                  3,315 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -806 mL
                                                                 -1,940 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///21/
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Skin:  Not assessed, Rash: Evolution in distribution but character
   similar--no bullae
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   8.6 g/dL
   63 K/uL
   108 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.9 mEq/L
   9 mg/dL
   105 mEq/L
   136 mEq/L
   25.4 %
   7.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
                            [**2144-10-21**]  03:48 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   7.2
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   25.4
   Plt
   58
   60
   65
   49
   64
   63
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   0.9
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   108
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:80.0 %, Band:7.0 %, Lymph:9.0 %,
   Mono:4.0 %, Eos:0.0 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L,
   LDH:200 IU/L, Ca++:7.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   48 yo male with history of HIV/HCV now admit with sepsis  and with
   hosptial course complicated by persistent fevers and evolution is
   significant rash consistent with medication reaction.  Of note,
   although fevers have persisted, hemodynamic stability has improved.
 .H/O BRADYCARDIA
 RASH
   -Very concerning for possible atypical reaction to vancomycin
   -WIll continue to treat symptomatically until resolution
 SHOCK, SEPTIC--Much improved stability, primary source remains to be
   defined.
   -ZOsyn to continue until course completed
   -Will continue to follow up outstanding cultures
   -Expect fevers to resolve as medicaiton reaction resolves
   -WIll need to continue to discuss closely with ID team
   -Will pick stop date for antibiotics and follow for fever resolution
   with minimal medications in effect
   -Lyme pending, will need to follow up on mycolytic cultures as well.
   ICU Care
   Nutrition: po diet, D/C foley
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-20**] 05:00 PM
   Prophylaxis:
   DVT: Boots and OOB
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 35 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Patient with rash felt by Dermatology consult to be most likely
   medication reaction which would be consistent with our impression as
   well.
   24 Hour Events:
 URINE CULTURE - At [**2144-10-20**] 05:00 PM
 FEVER - 103.5
F - [**2144-10-21**] 06:05 AM
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   Vancomycin
   Rash; rash comp
   Last dose of Antibiotics:
   Piperacillin - [**2144-10-18**] 10:00 PM
   Clindamycin - [**2144-10-20**] 08:30 AM
   Daptomycin - [**2144-10-20**] 08:00 PM
   Piperacillin/Tazobactam (Zosyn) - [**2144-10-21**] 06:08 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Flowsheet Data as of  [**2144-10-21**] 12:43 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 39.7
C (103.5
   Tcurrent: 38
C (100.4
   HR: 76 (70 - 93) bpm
   BP: 95/46(57) {83/34(48) - 112/62(68)} mmHg
   RR: 25 (10 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 66 Inch
   CVP: 3 (3 - 3)mmHg
   Total In:
                                                                  3,933 mL
                                                                  1,375 mL
   PO:
                                                                  2,200 mL
                                                                  1,050 mL
   TF:
   IVF:
                                                                  1,733 mL
                                                                    325 mL
   Blood products:
   Total out:
                                                                  4,739 mL
                                                                  3,315 mL
   Urine:
                                                                  4,739 mL
                                                                  3,315 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -806 mL
                                                                 -1,940 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///21/
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Skin:  Not assessed, Rash: Evolution in distribution but character
   similar--no bullae
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   8.6 g/dL
   63 K/uL
   108 mg/dL
   0.9 mg/dL
   21 mEq/L
   3.9 mEq/L
   9 mg/dL
   105 mEq/L
   136 mEq/L
   25.4 %
   7.2 K/uL
        [image002.jpg]
                             [**2144-10-17**]  10:58 AM
                             [**2144-10-17**]  01:34 PM
                             [**2144-10-17**]  05:05 PM
                             [**2144-10-17**]  06:59 PM
                             [**2144-10-18**]  03:51 AM
                            [**2144-10-19**]  03:00 AM
                            [**2144-10-20**]  02:12 AM
                            [**2144-10-21**]  03:48 AM
   WBC
   4.2
   4.1
   5.0
   3.2
   5.7
   7.2
   Hct
   29.6
   28.0
   29.5
   25.5
   24.9
   25.4
   Plt
   58
   60
   65
   49
   64
   63
   Cr
   0.7
   0.7
   0.8
   0.8
   0.8
   0.9
   TCO2
   18
   23
   Glucose
   104
   116
   130
   93
   100
   108
   Other labs: PT / PTT / INR:13.3/37.2/1.1, ALT / AST:46/51, Alk Phos / T
   Bili:49/0.8, Differential-Neuts:80.0 %, Band:7.0 %, Lymph:9.0 %,
   Mono:4.0 %, Eos:0.0 %, Fibrinogen:309 mg/dL, Lactic Acid:1.7 mmol/L,
   LDH:200 IU/L, Ca++:7.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   48 yo male with history of HIV/HCV now admit with sepsis  and with
   hosptial course complicated by persistent fevers and evolution is
   significant rash consistent with medication reaction.  Of note,
   although fevers have persisted, hemodynamic stability has improved.
 .H/O BRADYCARDIA
 RASH
   -Very concerning for possible atypical reaction to vancomycin
   -WIll continue to treat symptomatically until resolution
 SHOCK, SEPTIC--Much improved stability, primary source remains to be
   defined.
   -ZOsyn to continue until course completed
   -Will continue to follow up outstanding cultures
   -Expect fevers to resolve as medicaiton reaction resolves
   -WIll need to continue to discuss closely with ID team
   -Will pick stop date for antibiotics and follow for fever resolution
   with minimal medications in effect
   -Lyme pending, will need to follow up on mycolytic cultures as well.
   ICU Care
   Nutrition: po diet, D/C foley
   Glycemic Control:
   Lines:
   Multi Lumen - [**2144-10-17**] 08:15 AM
   18 Gauge - [**2144-10-20**] 05:00 PM
   Prophylaxis:
   DVT: Boots and OOB
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 35 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 48-year-old male with a history of HIV/HCV who was admitted with sepsis and developed a significant rash consistent with a medication reaction. The patient has been treated with various antibiotics, including vancomycin, and has been experiencing persistent fevers. Despite this, his hemodynamic stability has improved. The patient's rash has evolved in distribution but remains similar in character, with no bullae. The patient's laboratory results show elevated white blood cell count, platelet count, and lactate dehydrogenase levels, as well as abnormal liver function tests.

Potential medical complications that can arise:

1. Atypical reaction to vancomycin: The patient's rash is concerning for a possible atypical reaction to vancomycin, which can lead to severe complications if not addressed promptly.
2. Sepsis: The patient's persistent fevers and evolution of the rash suggest that the sepsis may not be fully resolved, which can lead to further complications if not managed effectively.
3. Shock: Although the patient's hemodynamic stability has improved, the risk of shock remains, particularly if the patient's infection is not fully controlled.
4. Medication reaction: The patient's rash is likely a medication reaction, which can lead to further complications if not managed effectively.
5. HIV/HCV complications: The patient's history of HIV/HCV increases the risk of complications related to these conditions, such as opportunistic infections and liver disease.
6. Liver dysfunction: The patient's abnormal liver function tests suggest that the patient may be at risk for liver dysfunction, which can lead to further complications if not managed effectively.
7. Respiratory failure: The patient's respiratory support is minimal, and the risk of respiratory failure remains, particularly if the patient's infection is not fully controlled.
8. Cardiovascular complications: The patient's bradycardia is concerning and may be a sign of underlying cardiovascular complications, such as heart failure or arrhythmias.
9. Neurological complications: The patient's neurological examination is limited, and the risk of neurological complications, such as seizures or encephalopathy, remains.
10. Infection control: The patient's prolonged hospital stay increases the risk of hospital-acquired infections, which can lead to further complications if not managed effectively."
